Weekly healthcare intelligenceRegulation · Enforcement · Government payersAll editions →

All articles and reminders · Compliance Sweep

Published November 15, 2026 · Reporting window November 8–14, 2026, Pacific. Later developments are labelled. Source coverage is incomplete; the complete reports describe the limitations.

All articlesSearch this edition →

27 articles and reminders, grouped by category.

Compliance Sweep

Higher-priority matters

Payment & health plan rules 2 articles and reminders

Payment & health plan rulesCompliance SweepNew in this edition

Federal IDR dispute web forms move into the IDR Gateway; disputes cannot start outside it after January 15, 2027

CMS's About Independent Dispute Resolution page, last modified November 13, 2026, says that as of November 13, 2026, users of the independent dispute resolution (IDR) Gateway can submit the Notice of IDR Initiation, IDR Entity Selection Response and Notice of Offer web forms in the Gateway. The single-use web forms will no longer be available outside the IDR Gateway after January 15, 2027, and parties will not be able to start a dispute outside the Gateway after that date. Organizations and individuals that process disputes, represent parties or submit IDR web forms must sign up to continue managing disputes in the IDR Gateway.

Medium priority · Nov 15, 2026 editionRead story →

Payment & health plan rulesCompliance SweepUpdated

CMS publishes CARE proposed rule (CMS-3484-P) in the Federal Register; comments assured consideration if received by January 11, 2027

The Federal Register published the Cutting Administrative Requirements for Excellence in Patient Care (CARE) proposed rule on November 10, 2026 at 91 FR 72634 (FR Doc. 2026-22812, docket CMS-3484-P). Its Dates section states that, to be assured consideration, comments must be received by January 11, 2027. The Federal Register record, read on November 15, 2026, lists no corrections. Nothing in the proposal is final; CMS's November 5, 2026 fact sheet describes the obstetric requirements it would remove as otherwise effective January 1, 2027; they would be removed only if CMS finalizes the proposal.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operations 14 articles and reminders

Governance & business operationsCompliance SweepUpdated

Medline bed recall: seven deaths and 35 serious injuries now reported; repair-and-replace customer guides coming

On November 13, 2026, FDA posted a Medline company announcement updating customers and patients on the repair and replace program for the recall of Medline Brand beds, rails, mattresses and accessories. Medline says that as of November 8, 2026 it has received reports related to seven deaths and 35 serious injuries associated with the fire hazard and entrapment issues, up from the two deaths and 16 serious injuries FDA's early alert reported as of October 20, 2026. Medline says it distributed the products in the United States and Canada between 2011 and 2026 to durable medical equipment providers, long-term care facilities and end users, and that it will soon begin distributing new repair and replace Customer Guides to patients and users. The continued-use instructions are unchanged: unplug the beds, plug in only while repositioning the patient, do not use extension cords, and have a second person assist whenever possible. To determine eligibility for repair, replacement or refund, customers contact the provider or distributor they bought or received the bed from, or Medline Recall Customer Service if they bought directly from Medline. On November 15, 2026, FDA's early alert page still showed content current as of October 29, 2026.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Arrow International removes catheters and guidewires with hydrophilic-coated spring wire guides over coating detachment and embolism risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Arrow International, a subsidiary of Teleflex Incorporated, which has told customers to remove certain products that contain Spring Wire Guide components. Arrow sent the letter on November 5, 2026, telling customers to check inventory, stop using and distributing affected product, quarantine it and return it. Teleflex confirmed that the hydrophilic coating may swell unevenly when hydrated with saline, clump and potentially detach. Detached coating could release particles into the bloodstream and raise the risk of emboli. As of November 5, 2026, the firm had reported no serious injuries or deaths.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA early alert: Intersurgical removes lots of 22mm Smoothbore breathing tubes and systems over connector disconnection and loss of ventilation risk

The Food and Drug Administration (FDA) posted an early alert on November 10, 2026 about Intersurgical Inc., which has told customers to remove listed lots of its 22mm Smoothbore breathing tubes and systems. Intersurgical sent the letter on November 3, 2026, telling customers to stop using and quarantine stock with the affected product and lot numbers and return it. Testing of internal stock found some products were made with too little solvent to secure the soft connectors to the tube. A connector that disconnects during use could cause loss of ventilation or compromised ventilation. As of November 3, 2026, the firm had reported no serious injuries or deaths.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

Eugia recalls one lot of vancomycin injection to the hospital level for glass particulate

Eugia US LLC announced on November 6, 2026 a voluntary nationwide recall, to the hospital/healthcare facility/user level, of one lot (3VM26026A) of Vancomycin Hydrochloride for Injection USP (United States Pharmacopeia) 1.25g/Vial-30mL because a glass particle was found inside a vial; FDA posted the announcement on November 9, 2026. The lot shipped to wholesalers nationwide from September 2 through September 15, 2026, and holders are told to discontinue use and quarantine it immediately.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

OHCA first-year provisional NOLA (labor-cost adjustment) requests still due November 16, 2026

California's Office of Health Care Affordability (OHCA) enforces health care spending targets set by its Health Care Affordability Board, and the law lets the Board adjust targets when non-supervisory organized labor costs are expected to grow faster than the target, through a Non-Supervisory Organized Labor Adjustment (NOLA). For the first year, OHCA must receive all requests for a provisional NOLA by November 16, 2026 (by the end of October in future years). NOLAs apply to providers and fully integrated delivery systems, not health plans; a labor union may initiate a request but the regulated entity must attest, and all NOLAs are provisional until confirmed with actual expenditure data.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

HemosIL AcuStar HIT-IgG(PF4-H) lot recall: destroy listed lots and document on the response form

FDA identified as the most serious type of recall the removal of four lots of an assay that, with other laboratory and clinical findings, aids in determining the risk for heparin-induced thrombocytopenia (HIT): HemosIL AcuStar HIT-IgG(PF4-H), from Instrumentation Laboratories (Werfen). Werfen found a performance issue in lots B40005, B40006, B38062 and B38063 that may cause a negative bias, so sample results could be incorrectly reported below the assay cut-off (1.00 U/mL) and be interpreted as HIT IgG antibody negative. The earlier article reported FDA's listing of the confirmed recall on October 30, 2026, and FDA says a supply interruption is expected.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

FDA early alert: ButterflyBVM bag-valve-mask resuscitators, removal of lots 000109 to 000117 and pre-use test for others

The Food and Drug Administration (FDA) issued an Early Alert on November 3, 2026 about Compact Medical's "Urgent Medical Device Recall" for certain lots of ButterflyBVM single-use bag-valve-mask resuscitators: lots 000109 through 000117 are to be removed, and listed earlier lots get a correction, to perform the Pre-Use Test before every use and not use any unit that fails. A hole can form in the bellows, which FDA says can cause inadequate ventilation and hypoxia; the firm sent letters on September 26 and October 7, 2026.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

StatStrip Gen 2.0 glucose meter Class I correction: interim safeguards until the software update

FDA identified Nova Biomedical's correction of its StatStrip Glucose Hospital Meter System as the most serious type of recall (Class I): on the Gen 2.0 model only, prior patient or quality-control information may remain on the meter screen when a barcode is scanned and, if accepted, assign a glucose result to the wrong patient. FDA issued its communication on October 20, 2026 and updated it on October 30 to clarify the recommended actions. Nova intends to roll out a software update in November 2026 in a phased manner; until then users follow updated instructions or, if an alternative meter is available, stop using the affected meter.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

B. Braun Dialog+ bloodline early alert: three Streamline Bloodline Set lots removed over connector detachment risk

FDA issued an Early Alert on a potentially high-risk device issue: B. Braun Medical Inc. has recommended to customers that lots A2600099, A2600128 and A2600136 of its Streamline Bloodline Set for Dialog+, model SL-2010M2096, be removed from where they are used or sold. B. Braun stated that a required solvent application step during assembly was not performed, leaving the dialyzer connector inadequately bonded, so the bloodline connector may detach or leak during priming or dialysis treatment, potentially leading to blood loss, clotting and occlusion of the extracorporeal circuit, or air entering the blood circuit. B. Braun sent customers a letter on October 20, 2026, and the earlier article reported FDA's device-safety listing of the alert on October 27, 2026.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepConditional reminder

Transparency in Coverage final rule: phased machine-readable file and phone-disclosure duties still ahead

The Transparency in Coverage final rule (FR Doc. 2026-20447, 91 FR 63748), published in the Federal Register on October 6, 2026 and effective December 7, 2026, sets new disclosure duties for non-grandfathered group health plans and health insurance issuers: in-network rate files for each provider network, out-of-network allowed-amount files for each health insurance market, new contextual files, a website footer link labeled Price Transparency or Transparency in Coverage, attestations in the files, and cost-sharing information available by phone. The duties phase in for plan years (policy years in the individual market) beginning on or after January 1, 2027 (the amended cost-sharing disclosures, including the phone method), on March 6, 2027 (the rate and allowed-amount file changes and attestations) and on September 6, 2027 (the contextual files and footer), with the first utilization file due July 1, 2028; until each date the prior rules continue to apply.

High priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepUpdated

CDPH submits readoption of acute psychiatric hospital nurse-to-patient ratio emergency regulations to OAL

The Office of Administrative Law (OAL) lists a California Department of Public Health (CDPH) emergency action titled Acute Psychiatric Hospitals, amending Title 22 sections that OAL lists as 71213 and 71215 (CDPH's October 30, 2026 All Facilities Letter names sections 71213.1 and 71215.1, and this difference was not resolved), as submitted on November 9, 2026 under OAL file 2026-1109-02EEFP. OAL's list covers proposed emergency actions that have been submitted and are currently under review. OAL must allow five calendar days for public comments after posting notice of an emergency filing, unless the emergency situation clearly poses such an immediate, serious harm that delaying action to allow public comment would be inconsistent with the public interest. On November 15, 2026, OAL had not posted a decision, and CDPH's rulemaking page for DPH-19-001E still showed only the original emergency history.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

FDA lists a Class I recall of four lots of the Edwards Commander M mitral valve delivery system over a manufacturing issue that may cause balloon rupture

The U.S. Food and Drug Administration's (FDA) Enforcement Report for the week of November 11, 2026 lists a Class I recall by Edwards Lifesciences, LLC of the Edwards Commander M Delivery System, model 9880CM29A, a delivery system for a percutaneously delivered mitral valve prosthesis. The recall covers lot numbers 67718561, 67804014, 67887043 and 67887044. The reason given is a manufacturing issue which may result in cardiovascular balloon rupturing.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

OHCA amended material change transaction rules took effect November 2; HCAI posts filing flowchart for management services organizations

The laws and regulations page of the Department of Health Care Access and Information (HCAI) states that the Office of Administrative Law approved amendments to the Office of Health Care Affordability (OHCA) Material Change Transactions and Pre-Transaction Review regulations, used for cost and market impact review (CMIR), on October 2, 2026, with a November 2, 2026 effective date (California Code of Regulations, title 22, sections 97431 through 97442). On November 10, 2026, HCAI posted a flowchart, marked New 11/2026, on when a management services organization (MSO) must file a material change transaction notice; it says it was developed for the regulations effective November 2, 2026. Under the flowchart, one threshold is an MSO owned by a hospital with one or more physician organization clients or affiliates. The approved text requires a health care entity or noticing entity that meets the filing criteria to give OHCA notice at least 90 days before the closing date of the transaction.

Medium priority · Nov 15, 2026 editionRead story →

Governance & business operationsCompliance SweepNew in this edition

California regulator tells health plans how downcoding must be disclosed and reviewed, with plan filings due November 23

On October 23, 2026, the California Department of Managed Health Care (DMHC) issued All Plan Letter (APL) 26-015 to all licensed health care service plans on downcoding, which the letter defines as paying a claim at a less complex or lower level of service than the provider billed. Plans must disclose the criteria and methods they use to pick claims for downcoding and to set the adjusted level, must review all supplemental documentation the provider submitted, which may include medical records, before downcoding, and must pay the portion of a claim the documentation supports. Each plan that has implemented or seeks to implement downcoding must make one compliance filing with DMHC by November 23, 2026.

Medium priority · Nov 15, 2026 editionRead story →

More matters and continuing watch

AI & digital health 1 articles and reminders

Governance & business operations 10 articles and reminders

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies